A carregar...
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design
BACKGROUND: Recurrence with papillary tumor(s) by 3-mo after induction bacillus Calmette-Guérin (BCG) is historically believed to be a poor prognostic indicator in patients with high-risk nonmuscle invasive bladder cancer. However, the impact of a clinical Ta (cTa) papillary recurrence at 3 mo after...
Na minha lista:
| Publicado no: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5115993/ https://ncbi.nlm.nih.gov/pubmed/26922408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.02.031 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|